NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-120-2001-0-BE-40 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses BE EP 10181776.5 Expired
NIAID E-120-2001-0-LI-50 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses LI EP 10181776.5 Expired
NIAID E-120-2001-0-NL-51 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses NL EP 10181776.5 Expired
NIAID E-120-2001-0-NL-32 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses NL EP 02739358.6 Expired
NIAID E-120-2001-0-IE-30 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses IE EP 02739358.6 Expired
NIAID E-120-2001-0-IT-31 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses IT EP 02739358.6 Expired
NIAID E-120-2001-0-DK-25 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses DK EP 02739358.6 Expired
NIAID E-120-2001-0-ES-26 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses ES EP 02739358.6 Expired
NIAID E-120-2001-0-SE-33 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses SE EP 02739358.6 Expired
NIAID E-120-2001-0-FI-27 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses FI EP 02739358.6 Expired
NIAID E-120-2001-0-DE-24 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses DE EP 02739358.6 Expired
NIAID E-120-2001-0-FR-28 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
4239-99178-01 		FR EP 02739358.6 Expired
NIAID E-120-2001-0-BE-22 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses BE EP 02739358.6 Expired
NIAID E-120-2001-0-AT-21 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses AT EP 02739358.6 Expired
NIAID E-120-2001-0-EP-03 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses EP National Stage 02739358.6 Expired
NIAID E-120-2001-0-CH-23 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses CH EP 02739358.6 Expired
NIAID E-120-2001-0-GB-29 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses GB EP 02739358.6 Expired
NIAID E-120-2001-0-TR-34 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses TR EP 02739358.6 Expired
NIAID E-120-2001-0-CA-05 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric CA National Stage 2448329 Expired
NIAID E-120-2001-0-AU-06 Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses AU National Stage 2002312011 Expired
NIAID E-120-2001-0-IN-08 A Method for Making Pharmeceutical Composition for Attenuating Dengue Viruses and Chimeric Dengue Viruses IN National Stage 2184/DELNP/2003 Abandoned
NIAID E-120-2001-0-PCT-02 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric PCT PCT PCT/US2002/016308 Expired
NCI E-152-2001-0-PCT-02 FOAMY VIRUS MUTANT REVERSE TRANSCRIPTASE PCT PCT PCT/US02/16528 Expired
NIAID E-133-1993-0-US-13 BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS US CON 10/153,273 6962987 Abandoned PDF
NCI E-281-2008-0-IN-01 Novel Lamda Phagc Display System And The Process IN ORD 566/Del/02 Expired
NCI E-065-2002-0-US-01 ELISA Assay of Serum Soluble CD22 To Assess Tumor Burden/Relapse In Patients With B-Cell Leukemia And Lymphoma US 60/382,269 Abandoned
NIDDK E-036-2007-0-US-01 Cloning And Characterization Of Calcitonin Gene Related Peptide Receptors US 60/381,911 Abandoned
NIDCR E-308-2001-0-US-02 Scalable Purification of Recombinant AAV2,AAV4 Or AAV5 Vectors Using Ion Exchange Chromatography US ORD 10/166,347 7419817 Issued PDF
NIAID E-031-2004-0-US-01 Methods Of Use And Compositions For The Diagnosis And Treatment Of Infectious Disease US ORD 10/147,587 6951961 Expired PDF
CC E-176-2001-0-PCT-02 Compositions And Methods For Magnetically Labeling Cells PCT PCT PCT/US02/15597 Expired
NINDS E-082-2002-0-US-01 METHOD OF ASSESSING ISCHEMIA IN A PATIENT US 60/381,611 Abandoned
NIDCR E-308-2001-0-US-01 SCALABLE PURIFICATION OF AAV2, AAV4 OR AAV5 USING ION-EXCHANGE CHROMATOGRAPHY. US 60/381,180 Abandoned
NIAID E-031-2004-0-US-02 Methods Of Use And Compositions For The Diagnosis And Treatment Of Infectious Disease US 60/381,220 Abandoned
NCI E-017-2002-0-US-01 SCYTOVIRINS AND RELATED CONJUGATES, FUSION PROTEINS, NUCLEIC ACIDS, VECTORS, HOST CELLS, COMPOSITIONS, ANTIODIES, AND METHODS OF USING... US 60/381,322 Abandoned
NCI E-002-2001-0-PCT-02 tumor Antigen Homologous To Poly (A) Polymerase PCT PCT PCT/US02/15537 Abandoned
NCI E-142-1990-2-US-04 AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY US DIV 10/147,140 Abandoned
NCI E-083-2002-1-US-01 DISCOIDIN DOMAIN RECEPTOR 1 ISOFORM-B (DDR1B) IN RESPONSE TO COLLAGEN TRANSDUCES SIGNALS THAT PROMOTE DIFFERENTIATION OF PHORBOL ESTER- PRIMED HUMAN MONOCYTIC CELLS US 60/380,978 Abandoned
NIAID E-100-1999-0-US-04 Cloned Genome of Infectious Hepatitis C Virus of Genotype 2A and Uses Thereof US National Stage 09/980,559 7084266 Expired PDF
NICHD E-184-2001-1-PCT-01 Modified Growth Hormone PCT PCT COMB PCT/US02/15172 Expired
NCI E-200-1998-0-US-36 Multidrug-Resistant Retroviral Protease Inhibitors, Compostions and Uses Thereof, Bioassay Methods, and Synthesis Methods US National Stage 10/130,159 Abandoned
NCI E-019-2000-2-US-02 INHIBITION OF ABC TRANSPORTERS BY TRANSMENBRANE DOMAIN ANALOGS US National Stage 10/130,192 7517849 Abandoned PDF
NCI E-200-2002-0-US-01 Persistent HIV-1 Infection of Natural Killer Cells In Patients Receiving Highly Active Antiretroviral Therapy US 60/380,555 Abandoned
NHGRI E-004-2002-0-US-01 USE OF HOMO SAPIENS CHROMOSOME 1 OPEN READING FRAME 28 (C1ORF28) IN THE DIAGNOSIS OF HYPERPARATHYROIDISM-JAW TUMOR SYNDROME (HPT-JT) US 60/378,022 Abandoned
NIA E-176-2002-0-US-01 Modified Oligonucleotide And Methods of Use Thereof US 60/378,025 Abandoned
NIMH E-174-2000-0-US-03 Effect of COMT Genotype on Frontal Lobe Function US ORD 10/144,000 Abandoned
NCI E-189-2002-0-US-01 POLYDIAZENIUMDIALATED CYCLIC POLYAMINES WITH POLYPHASIC NITRIC OXIDE RELEASE AND RELATED COMPOUNDS, COMPOSITIONS COMPRISING SAME AND... US 60/378,495 Abandoned
NCI E-144-2002-0-US-01 IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING ALTERNATING ANTIGEN PANNING OF PHAGE...
. 		US 60/378,408 Abandoned
NCI E-144-2002-1-US-01 Identification of Novel Broadly Cross-Reactive HIV 1 Neutralizing Human Monoclonal Antibodies US 60/378,406 Abandoned
NCI E-160-1997-2-US-02 Polynucleotides Encoding Human FRP and Fragments Thereof US DIV 10/138,434 7183377 Abandoned PDF
NCI E-046-1994-0-US-11 FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS US DIV 10/139,614 Abandoned